Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The G protein beta-gamma subunit complex (Gβγ) is a tightly bound dimeric component of heterotrimeric G proteins associated with G protein-coupled receptors (GPCRs). In its inactive state, Gβγ binds Gα-GDP to maintain the heterotrimer and enhance Gα affinity for GDP; upon GPCR activation, GTP exchange on Gα leads to dissociation, freeing Gβγ to act as a signaling molecule that regulates diverse effectors including ion channels (e.g., activating GIRK channels, inhibiting voltage-gated calcium channels), enzymes like phospholipase Cβ and adenylyl cyclase, and kinases such as GRK2 for receptor desensitization.[1][2][3] There are five mammalian Gβ subtypes (β-propeller structures with WD repeats) and eleven Gγ subtypes (prenylated for membrane targeting), allowing combinatorial specificity in signaling.[2] Gβγ plays key roles in heart function by recruiting GRK2 to desensitize β-adrenergic receptors, contributing to heart failure pathology; inhibiting this interaction with agents like GRK2ct improves cardiac contractility in models.[2] In inflammation, Gβγ activates PI3Kγ downstream of chemokine GPCRs to promote neutrophil recruitment.[2] It also drives leukemia via RhoGEF activation and chemotaxis.[2] As a therapeutic target, Gβγ modulation offers potential in cardiovascular disease, inflammation, and cancer, though challenges include preserving Gα signaling and avoiding broad GPCR disruption.[1][2]
Inhibition of Gβγ-GRK2 interaction to prevent receptor desensitization; Blocking Gβγ signaling to effectors like PI3Kγ or RhoGEF; Prenylation inhibition of Gγ subunit
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein beta-gamma subunit complex (Gβγ complex).